285 related articles for article (PubMed ID: 37578350)
1. Clinical Theranostics Trademark of Exosome in Glioblastoma Metastasis.
Nag S; Bhattacharya B; Dutta S; Mandal D; Mukherjee S; Anand K; Eswaramoorthy R; Thorat N; Jha SK; Gorai S
ACS Biomater Sci Eng; 2023 Sep; 9(9):5205-5221. PubMed ID: 37578350
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miRNAs and breast cancer: a complex theranostics interlink with clinical significance.
Mukherjee S; Dhar R; Jonnalagadda S; Gorai S; Nag S; Kar R; Mukerjee N; Mukherjee D; Vatsa R; Arikketh D; Krishnan A; Gundamaraju R; Jha SK; Alexiou A; Papadakis M
Biomarkers; 2023 Sep; 28(6):502-518. PubMed ID: 37352015
[TBL] [Abstract][Full Text] [Related]
3. Clinical Impact of Exosomes in Colorectal Cancer Metastasis.
Ghosh S; Dhar R; Gurudas Shivji G; Dey D; Devi A; Jha SK; Adhikari MD; Gorai S
ACS Appl Bio Mater; 2023 Jul; 6(7):2576-2590. PubMed ID: 37314223
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles in the glioblastoma microenvironment: A diagnostic and therapeutic perspective.
Russo MN; Whaley LA; Norton ES; Zarco N; Guerrero-Cázares H
Mol Aspects Med; 2023 Jun; 91():101167. PubMed ID: 36577547
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles in Glioma: From Diagnosis to Therapy.
Basu B; Ghosh MK
Bioessays; 2019 Jul; 41(7):e1800245. PubMed ID: 31188499
[TBL] [Abstract][Full Text] [Related]
7. Self-Functionalized Superlattice Nanosensor Enables Glioblastoma Diagnosis Using Liquid Biopsy.
Premachandran S; Haldavnekar R; Ganesh S; Das S; Venkatakrishnan K; Tan B
ACS Nano; 2023 Oct; 17(20):19832-19852. PubMed ID: 37824714
[TBL] [Abstract][Full Text] [Related]
8. Exosomes: A Cutting-Edge Theranostics Tool for Oral Cancer.
Kalele K; Nyahatkar S; Mirgh D; Muthuswamy R; Adhikari MD; Anand K
ACS Appl Bio Mater; 2024 Mar; 7(3):1400-1415. PubMed ID: 38394624
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells.
de Vrij J; Maas SL; Kwappenberg KM; Schnoor R; Kleijn A; Dekker L; Luider TM; de Witte LD; Litjens M; van Strien ME; Hol EM; Kroonen J; Robe PA; Lamfers ML; Schilham MW; Broekman ML
Int J Cancer; 2015 Oct; 137(7):1630-42. PubMed ID: 25802036
[TBL] [Abstract][Full Text] [Related]
10. Breaking through the glioblastoma micro-environment via extracellular vesicles.
Simon T; Jackson E; Giamas G
Oncogene; 2020 Jun; 39(23):4477-4490. PubMed ID: 32366909
[TBL] [Abstract][Full Text] [Related]
11. Digging the intercellular crosstalk via extracellular vesicles: May exosomes be the drug delivery solution for target glioblastoma?
Macedo-Pereira A; Martins C; Lima J; Sarmento B
J Control Release; 2023 Jun; 358():98-115. PubMed ID: 37120033
[TBL] [Abstract][Full Text] [Related]
12. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
[TBL] [Abstract][Full Text] [Related]
13. Haematopoietic cell-derived exosomes in cancer development and therapeutics: From basic science to clinical practice.
Lin WC; Lin YT; Chao HC; Lin YY; Hwang WL
Clin Transl Med; 2023 Oct; 13(10):e1448. PubMed ID: 37830387
[TBL] [Abstract][Full Text] [Related]
14. Theranostic signature of tumor-derived exosomes in cancer.
Kumar S; Dhar R; Kumar LBSS; Shivji GG; Jayaraj R; Devi A
Med Oncol; 2023 Oct; 40(11):321. PubMed ID: 37798480
[TBL] [Abstract][Full Text] [Related]
15. Small extracellular vesicles as tumor biomarkers for glioblastoma.
Mahmoudi K; Ezrin A; Hadjipanayis C
Mol Aspects Med; 2015 Nov; 45():97-102. PubMed ID: 26118341
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment.
Dai J; Jiang Y; Hu H; Zhang S; Chen Y
Pathol Oncol Res; 2024; 30():1611549. PubMed ID: 38379858
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients.
Santiago-Dieppa DR; Steinberg J; Gonda D; Cheung VJ; Carter BS; Chen CC
Expert Rev Mol Diagn; 2014 Sep; 14(7):819-25. PubMed ID: 25136839
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles in the biology of brain tumour stem cells--Implications for inter-cellular communication, therapy and biomarker development.
Nakano I; Garnier D; Minata M; Rak J
Semin Cell Dev Biol; 2015 Apr; 40():17-26. PubMed ID: 25721810
[TBL] [Abstract][Full Text] [Related]
19. Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.
Zeng AL; Yan W; Liu YW; Wang Z; Hu Q; Nie E; Zhou X; Li R; Wang XF; Jiang T; You YP
Oncogene; 2017 Sep; 36(38):5369-5381. PubMed ID: 28504721
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.
Saadatpour L; Fadaee E; Fadaei S; Nassiri Mansour R; Mohammadi M; Mousavi SM; Goodarzi M; Verdi J; Mirzaei H
Cancer Gene Ther; 2016 Dec; 23(12):415-418. PubMed ID: 27834360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
